Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination
Prestige Consumer Healthcare Inc. (PBH)
Last prestige consumer healthcare inc. earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.prestigebrands.com
Company Research
Source: GlobeNewswire
TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contaminated food. The second type can cause stomach cramps and diarrhea that can start 8 to 16 hours after eating or drinking contaminated food. Diarrhea may be a small volume or profuse and watery. Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death. The affected lots were distributed nationwide in the United States through retailers and online from 12/14/2022 through 06/04/2025. The table below identifies the UPC, lot n
Show less
Read more
Impact Snapshot
Event Time:
PBH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBH alerts
High impacting Prestige Consumer Healthcare Inc. news events
Weekly update
A roundup of the hottest topics
PBH
News
- Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $100.00 to $88.00. They now have a "buy" rating on the stock.MarketBeat
- Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 ResultsGlobeNewswire
- Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Jefferies Financial Group Inc. from $75.00 to $71.00. They now have a "hold" rating on the stock.MarketBeat
- Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.MarketBeat
PBH
Earnings
- 11/6/25 - Beat
PBH
Sec Filings
- 12/2/25 - Form 4
- 12/1/25 - Form 144
- 11/28/25 - Form 144
- PBH's page on the SEC website